The rising trend of prescribing weight-loss medications to young children raises serious ethical and medical concerns. Experts debate whether pharmaceutical interventions are appropriate for six-year-olds, questioning if society is abandoning traditional approaches to childhood obesity. This controversy highlights the need for evidence-based policies balancing healthcare innovation with child protection and long-term developmental safety.

Summary auto-generated by AI from the original publisher's content. Editorial standards.